Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,700
Closed -$480K 573
2020
Q3
$480K Buy
9,700
+1,361
+16% +$76.8K 0.01% 446
2020
Q2
$294K Hold
8,339
0.01% 458
2020
Q1
$294K Hold
8,339
0.01% 458
2019
Q4
$720K Hold
8,339
0.02% 416
2019
Q3
$707K Hold
8,339
0.02% 437
2019
Q2
$877K Buy
8,339
+1,700
+26% +$171K 0.02% 401
2019
Q1
$701K Hold
6,639
0.02% 462
2018
Q4
$556K Sell
6,639
-34,000
-84% -$3.08M 0.01% 480
2018
Q3
$4.14M Hold
40,639
0.06% 199
2018
Q2
$3.29M Sell
40,639
-9,061
-18% -$720K 0.05% 251
2018
Q1
$3.66M Hold
49,700
0.05% 238
2017
Q4
$3.5M Hold
49,700
0.05% 259
2017
Q3
$3.1M Hold
49,700
0.06% 216
2017
Q2
$2.85M Sell
49,700
-59,500
-54% -$3.5M 0.08% 217
2017
Q1
$6.64M Buy
109,200
+54,600
+100% +$3.09M 0.08% 250
2016
Q4
$3M Hold
54,600
0.08% 181
2016
Q3
$2.52M Buy
54,600
+35,700
+189% +$1.51M 0.07% 225
2016
Q2
$643K Buy
+18,900
New +$590K 0.02% 595

Other funds holding NGVT

Barings's NGVT Position: Q4 2020 in Review

Barings sold out of Ingevity (NGVT) in Q4 2020, closing a stake of 9,700 shares — an estimated $480K sold.

Barings first reported a position in NGVT in Q2 2016 and held it in 18 quarters. The position peaked at $6.64M in Q1 2017. 285 funds tracked by Wall St. Rank hold NGVT as of Q4 2020.

  • Barings reported no remaining Ingevity position as of Q4 2020 after selling out during the quarter.
  • Barings sold 9,700 Ingevity shares in Q4 2020, an estimated $480K.
  • Barings first reported a position in Ingevity in Q2 2016 and held it in 18 quarters.
  • Barings's Ingevity position peaked at $6.64M in Q1 2017.
  • 285 funds tracked by Wall St. Rank held Ingevity as of Q4 2020.

Based on Barings's 13F filing for Q4 2020, filed 16 Feb 2021.